Anti-IL-2 receptor antibodies as models for cancer therapy [electronic resource] / Thomas A. Waldmann.

By: Waldmann, Thomas, 1930- [spk]Material type: FilmFilmSeries: Henry Stewart talksBiomedical & life sciences collection. Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances: Publisher: London : Henry Stewart Talks, 2007Description: 1 online resource (1 streaming video file (45 min.) : color, sound)Subject(s): Antibodies, Monoclonal -- therapeutic use | Autoimmune Diseases -- therapy | Leukemia -- therapy | Receptors, Interleukin-2Online resources: Click here to access online | Series
Contents:
Contents: Structure and function of IL-2 receptor -- Disorders of IL-2 receptor expression in disease -- IL-2R alpha-directed monoclonal antibody mediated therapy of leukemia and autoimmune diseases -- Anti-IL-2E alpha monoclonals armed with toxins or radionuclides -- IL-15 and its use of the IL-/IL-15 beta receptor -- IL-2/IL-15 R beta receptor directed therapy for leukemia and autoimmune diseases -- The IL-2R alpha as a target in the elimination of CD4+ CD25+ T-regs (suppressor cells).
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
No physical items for this record

Animated audio-visual presentation with synchronized narration.

Title from title frames.

Contents: Structure and function of IL-2 receptor -- Disorders of IL-2 receptor expression in disease -- IL-2R alpha-directed monoclonal antibody mediated therapy of leukemia and autoimmune diseases -- Anti-IL-2E alpha monoclonals armed with toxins or radionuclides -- IL-15 and its use of the IL-/IL-15 beta receptor -- IL-2/IL-15 R beta receptor directed therapy for leukemia and autoimmune diseases -- The IL-2R alpha as a target in the elimination of CD4+ CD25+ T-regs (suppressor cells).

Access restricted to subscribers.

Mode of access: World Wide Web.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571